Patient Support Program Triumphs

A patient support program offering around the clock assistance to glioblastoma multiforme (GBM) patients undergoing an innovative therapy has been named the Most Valuable Patient Initiative award at eyeforpharma ’s annual awards ceremony in Philadelphia.   Reflecting on the win, Novocure said: “We are humbled to have helped so many patients and to be recognised for it by our peers who have made careers out of trying to help patients in the most need. The eyeforpharma awards are helping pharma to focus on its core constituent — the patient.”  In naming the PSP as the winner of the 2018 Most Valuable Patient Initiative award, the panel of expert judges — comprising patients, patient advocates, healthcare professionals and senior pharma executives — hailed the project as “outstandingly innovative”, particularly in supporting patients through the access stage.How did it come about?The oncology company identified a clear need to provide additional support to patients usingOptune, its FDA-approved, wearable technology.The therapeutic device, which is designed to treat patients with glioblastoma multiforme (GBM), generates low-intensity electric fields called tumour treating fields, or TTFields, that helps slow or stop glioblastoma cancer cells from dividing and may also cause some of them to die.The patient is responsible for the continuous use of the device, which threw up unique lifestyle challenges that had to be addressed.Novocure launched a program called nC...
Source: EyeForPharma - Category: Pharmaceuticals Authors: Source Type: news